Market Research Logo

Global Immunoglobulin Products Market 2016-2020

About Immunoglobulin Products

Immunoglobulins, also known as antibodies, are proteins that help neutralize foreign objects such as bacteria and viruses. They help recognize and bind to particular antigens. Based on the difference in the amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes: IgA, IgD, IgE, IgG, and IgM. In 1952, immunoglobulin products were used for the first time to treat immune deficiency. They can be administered by either the intravenous (IV) or subcutaneous (SC) route. Immunoglobulin products given intravenously usually contain IgG. Immunoglobulin products are used to treat primary antibody deficiency, complex immune deficiency disorders, and life threatening infections. Immunoglobulin therapeutic products help prevent infections, improving the quality of life and increasing life expectancy.

Technavio’s analysts forecast the global immunoglobulin products market to grow at a CAGR of 6.84% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global immunoglobulin products market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of immunoglobulin products used to treat various autoimmune and immunodeficiency diseases.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Immunoglobulin Products Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Baxalta
  • Biotest Pharmaceuticals Corp.
  • CSL Ltd.
  • Grifols SA
  • Kedrion SpA
  • Octapharma
Other prominent vendors
  • Abeona Therapeutics
  • Admabiologics
  • Anthera
  • Beijing Tiantan Biological Products (China)
  • Bharat Serums and Vaccines (India)
  • Bio Products Laboratory
  • China Biologic Products (China)
  • Emergent Biosolutions
  • Gliknik
  • Greencross
  • Hansamedical
  • Hualan Biological Engineering (China)
  • Immunomedics
  • Innate Pharma
  • Integrated Biotherapeutics
  • Janssen Pharmaceuticals
  • Kamada
  • LFB Group (France)
  • Mitsubishi Tanabe Pharma
  • Momenta Pharma
  • Patrys
  • Shanghai RAAS Blood Products (China)
  • Sichuan Yuanda Shuyang Pharmaceutical (China)
  • Sorrento Therapeutics
Market driver
  • Growing aging population
  • For a full, detailed list, view our report
Market challenge
  • High cost of therapy
  • For a full, detailed list, view our report
Market trend
  • Patient assistance programs
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Immunoglobulin Products Market 2016-2020

Technavio recognizes the following companies as the key players in the Global Immunoglobulin Products Market: Baxalta, Biotest Pharmaceuticals Corp., CSL Ltd., Grifols SA, Kedrion SpA, and Octapharma.

Other Prominent Vendors in the market are: Abeona Therapeutics, Admabiologics, Anthera, Beijing Tiantan Biological Products (China), Bharat Serums and Vaccines (India), Bio Products Laboratory, China Biologic Products (China), Emergent Biosolutions, Gliknik, Greencross, Hansamedical, Hualan Biological Engineering (China), Immunomedics, Innate Pharma, Integrated Biotherapeutics, Janssen Pharmaceuticals, Kamada, LFB Group (France), Mitsubishi Tanabe Pharma, Momenta Pharma, Patrys, Shanghai RAAS Blood Products (China), Sichuan Yuanda Shuyang Pharmaceutical (China), and Sorrento Therapeutics.

Commenting on the report, an analyst from Technavio’s team said: “As plasma therapeutics are often expensive, vendors provide co-pay assistance to patients to enable the purchase of these drugs. For instance, Baxter's Gammagard liquid support program provides financial assistance to individuals with primary immunodeficiency. According to the Gammagard Liquid SubQ CoPay card, an eligible patient receiving treatment with Gammagard Liquid SubQ for primary immunodeficiency is entitled to save up to $2,500 on the coinsurance/co-payment costs over a 12-month period.”

According to the report, growing older population is driving the market growth. The immune system becomes weak with age, causing many immune deficiency syndromes. Individuals with immune deficiency require immunoglobulin products for proper functioning of the immune system.

Further, the report states that immunoglobulin products are produced from plasma, and obtaining high-quality plasma is an expensive and challenging exercise. Moreover, the cost of immunoglobulin is dependent on the availability of human donors. Fractionation of plasma is the standard method of producing immunoglobulins and is a highly complex procedure.

Companies Mentioned

Baxalta, Biotest Pharmaceuticals Corp., CSL Ltd., Grifols SA, Kedrion SpA, Octapharma, Abeona Therapeutics, Admabiologics, Anthera, Beijing Tiantan Biological Products (China), Bharat Serums and Vaccines (India), Bio Products Laboratory, China Biologic Products (China), Emergent Biosolutions, Gliknik, Greencross, Hansamedical, Hualan Biological Engineering (China), Immunomedics, Innate Pharma, Integrated Biotherapeutics, Janssen Pharmaceuticals, Kamada, LFB Group (France), Mitsubishi Tanabe Pharma, Momenta Pharma, Patrys, Shanghai RAAS Blood Products (China), Sichuan Yuanda Shuyang Pharmaceutical (China), Sorrento Therapeutics.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
    • Assumptions
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Plasma products: An overview
    • Components of blood plasma
      • Table Composition of blood
      • Table Composition of plasma
    • Manufacturing process of plasma products
      • Table Total collection of plasma in US 2010-2014 (in liters)
      • Table Projected fractionation capacity of manufacturing units in US and EU (millions of liters/annum)
      • Table Process of procurement and manufacturing of plasma products
    • Clinical uses of plasma
    • Cost of plasma therapeutics
  • Regulation of plasma products
    • Table Regulatory policies of plasma protein therapy lifecycle
  • Pipeline portfolio
    • Table Pipeline molecules for immunoglobulin products
    • Table Pipeline share of immunoglobulin products 2015
    • Information on few pipeline candidates
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global immunoglobulin products market 2015-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by type of immunoglobulins
    • Table Global immunoglobulin products market segment by type of immunoglobulins
    • Table Global immunoglobulin products market share by type of immunoglobulins 2015
  • Market segmentation by application
    • Table Global immunoglobulin products market segmentation by application
    • Immunodeficiency diseases
    • Hypogammaglobulinemia
    • CIDP
    • Congenital AIDS
    • CLL
    • Myasthenia gravis
    • MMN
    • ITP
    • Kawasaki disease
    • Guillain-Barré syndrome
    • Others
      • Table Global immunoglobulin products market share by application
  • Market segmentation by ROA
    • Table Global immunoglobulin products market segment by ROA
    • Table Global immunoglobulin products market share by ROA2015
    • IVIG products
      • Table Global IVIG products market 2015-2020 ($ billions)
    • SCIG products
      • Table Global SCIG products market 2015-2020 ($ billions)
    • IMIG products
      • Table Global IMIG products market 2015-2020 ($ billions)
      • Table Global immunoglobulin products market revenue by ROA 2015-2020 ($ billions)
      • Table Global immunoglobulin products market YoY revenue and growth based on ROA 2015-2020 ($ billions)
  • Market segmentation by volume
    • Table Global immunoglobulin products market by volume 2015
    • Table Global immunoglobulin products by volume 2015 and 2020 (tons)
    • Market overview
      • Table Global immunoglobulin products market by volume 2015-2020 (tons)
      • Table Average immunoglobulin consumption by country (Kilograms per million people) 2012
    • Immunoglobulin products market by volume in Americas
      • Table Immunoglobulin products market in Americas by volume 2015-2020 (tons)
    • Immunoglobulin products market by volume in EMEA
      • Table Global immunoglobulin products market by volume 2015-2020 (tons)
    • Immunoglobulin products market by volume in APAC
      • Table Immunoglobulin products market in EMEA by volume 2015-2020 (tons)
  • Geographical segmentation
    • Table Global immunoglobulin products market by geography 2015
    • Table Global immunoglobulin products market revenue by geography 2015-2020 ($ billions)
    • Immunoglobulin products market in Americas
      • Table Immunoglobulin products market in Americas 2015-2020 ($ billions)
    • Immunoglobulin products market in EMEA
      • Table Immunoglobulin products market in EMEA 2015-2020 ($ billions)
    • Immunoglobulin products market in APAC
      • Table Immunoglobulin products market in APAC 2015-2020 ($ billions)
      • Table Global immunoglobulin products market YoY revenue and growth based on geography 2015-2020
  • Market drivers
    • Growing older population
      • Table Population aged 60 years and over: World, developed, and developing regions (millions)
    • Increase in individuals with PID
    • Promising pipeline
    • Approval of immunoglobulins to treat neuroimmunological disorders
    • Rise in demand for IVIG therapies
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • High cost of therapy
    • Product recalls by US FDA
    • Limited plasma fractionation capacity
    • Post-transfusion adverse reactions
    • Stringent regulatory guidelines
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Patient assistance programs
    • Strategic alliances and M&A
    • Increased use of synthetic/recombinant products
    • Rise in awareness of PID
  • Vendor landscape
    • Competitive scenario
    • Market share analysis 2015
      • Table Global immunoglobulin products market share analysis 2015
      • Table Market share analysis of top vendors 2015
    • CSL
      • Table CSL: Immunoglobulins products segmentation
      • Table Key takeaways
    • Baxalta
      • Table Baxalta: Product categories by revenue 2015
      • Table Baxalta: YoY revenue comparison of immunoglobulin therapy area 2014 and 2015
      • Table Baxalta: Geographic segmentation of immunoglobulin therapies by revenue 2015
      • Table CSL: Key takeaways
    • Grifols
      • Table Grifols: YoY growth rate and revenue of bioscience segment 2013-2015 ($ billions)
      • Table Grifols: Key takeaways
    • Octapharma
      • Table Octapharma: Key takeaways
    • Kedrion
      • Table Kedrion: Key takeaways
    • Biotest Pharmaceuticals
      • Table Biotest: Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report